321 related articles for article (PubMed ID: 19240260)
1. Role of huperzine a in the treatment of Alzheimer's disease.
Desilets AR; Gickas JJ; Dunican KC
Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
[TBL] [Abstract][Full Text] [Related]
2. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
Pilotaz F; Masson P
Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
Zhang HY; Tang XC
Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):941-4. PubMed ID: 12181083
[TBL] [Abstract][Full Text] [Related]
5. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
6. Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.
Tang XC
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):481-4. PubMed ID: 9863136
[TBL] [Abstract][Full Text] [Related]
7. An update on huperzine A as a treatment for Alzheimer's disease.
Little JT; Walsh S; Aisen PS
Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A from Huperzia species--an ethnopharmacolgical review.
Ma X; Tan C; Zhu D; Gang DR; Xiao P
J Ethnopharmacol; 2007 Aug; 113(1):15-34. PubMed ID: 17644292
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
Liu WH; Song JL; Liu K; Chu DF; Li YX
J Control Release; 2005 Oct; 107(3):417-27. PubMed ID: 16154224
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
[TBL] [Abstract][Full Text] [Related]
12. Huperzine A for Alzheimer's disease.
Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
[TBL] [Abstract][Full Text] [Related]
13. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
Patocka J
Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
Cummings JL; Mackell J; Kaufer D
Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
[TBL] [Abstract][Full Text] [Related]
16. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS;
Neurology; 2011 Apr; 76(16):1389-94. PubMed ID: 21502597
[TBL] [Abstract][Full Text] [Related]
19. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer's disease therapy--theory and practice].
Gabryelewicz T; Barcikowska M; Jarczewska DL
Wiad Lek; 2005; 58(9-10):528-35. PubMed ID: 16529064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]